Approval · Notice of Compliance 9528 · 2008
LUCENTIS: Notice of Compliance 9528
Issued April 30, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9528
- Date
- April 30, 2008
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-neovascularisation agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUCENTIS | 02296810 | Marketed |
Medicinal ingredients
- RANIBIZUMAB 10 MG per ML